Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Data From Routine Lung Cancer Visits Yield Research Insights

Key clinical point: Creating a database of clinical and genetic information from clinical visits is feasible and useful for oncology research.

Major finding: Among 3,522 patients with advanced disease, the median overall survival was 10.3 months and the 5-year survival rate was 3.8%.

Study details: The study population included 4,064 adults with non–small cell lung cancer.

Disclosures: The study was supported by Flatiron Health and Foundation Medicine, which are both owned by the Roche Group. Dr. Singal and several coauthors are employees of Foundation Medicine.


Singal G et al. JAMA. 2019;321:1391-9.